Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;184(1):68-77.
doi: 10.1111/bjd.19022. Epub 2020 Apr 27.

Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study

M S M Persson  1 , K E Harman  1 , Y Vinogradova  2 , S M Langan  3 , J Hippisley-Cox  4 , K S Thomas  1 , S Gran  1
Affiliations

Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study

M S M Persson et al. Br J Dermatol. 2021 Jan.

Abstract

Background: A rising incidence and high mortality were found for bullous pemphigoid (BP) over a decade ago in the UK. Updated estimates of its epidemiology are required to understand the healthcare needs of an ageing population.

Objectives: To determine the incidence, prevalence and mortality rates of BP in England from 1998 to 2017.

Methods: We conducted a cohort study of longitudinal electronic health records using the Clinical Practice Research Datalink and linked Hospital Episode Statistics. Incidence was calculated per 100 000 person-years and annual point prevalence per 100 000 people. Multivariate analysis was used to determine incidence rate ratios by sociodemographic factors. Mortality was examined in an age-, sex- and practice-matched cohort, using linked Office of National Statistics death records. Hazard ratios (HRs) were stratified by matched set.

Results: The incidence was 7·63 [95% confidence interval (CI) 7·35-7·93] per 100 000 person-years and rose with increasing age, particularly for elderly men. The annual increase in incidence was 0·9% (95% CI 0·2-1·7). The prevalence almost doubled over the observation period, reaching 47·99 (95% CI 43·09-53·46) per 100 000 people and 141·24 (95% CI 125·55-158·87) per 100 000 people over the age of 60 years. The risk of all-cause mortality was highest in the 2 years after diagnosis (HR 2·96; 95% CI 2·68-3·26) and remained raised thereafter (HR 1·54; 95% CI 1·36-1·74).

Conclusions: We report a modest increase in the incidence rate of BP, but show that the burden of disease in the elderly population is considerable. Mortality is high, particularly in the first 2 years after diagnosis.

PubMed Disclaimer

Comment in

References

    1. Ständer S, Färber B, Radeke S et al. Assessment of the healthcare costs for patients with pemphigus and bullous pemphigoid in an academic centre in Germany. Br J Dermatol 2020; doi: 10.1111/bjd.18731.
    1. Kouris A, Platsidaki E, Christodoulou C et al. Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control study. An Bras Dermatol 2016; 91:601-3.
    1. Langan S, Smeeth L, Hubbard R et al. Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study. BMJ 2008; 337:a180.
    1. Persson MSM, Harman KE, Vinogradova et al. Incidence, prevalence, and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study. Br J Dermatol 2020; doi: 10.1111/bjd.19022.
    1. Benchimol EI, Smeeth L, Guttmann A et al.; RECORD Working Committee. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 2015; 12:e1001885.

Publication types